Overview

This bill amends the Mesothelioma Act 2014 to add a research supplement to the existing levy on insurers. This supplement will fund research into mesothelioma, a cancer linked to asbestos exposure.

Description

The Mesothelioma (Amendment) Bill adds a new section to the 2014 Act. This allows for a "research supplement" to be included in the levy paid by insurers. This supplement:

• Will be a percentage (up to 1%) of the existing levy amount.
• Will be used to fund mesothelioma research via grants or other financial assistance.
• Will be managed by the scheme administrator, potentially with the help of a research funding body.
• May allow for funds collected in one period to be allocated later.

Before implementing the supplement, the Secretary of State must consult insurers, medical charities, research foundations, and other relevant stakeholders.

Government Spending

The bill does not directly increase or decrease government spending. Instead, it creates a mechanism for a small percentage of existing levy funds to be redirected towards mesothelioma research. The exact amount will depend on the levy and the percentage allocated to research. No figures are provided in the bill text.

Groups Affected

• Insurers: Will pay a slightly increased levy.
• Medical charities and research foundations: May receive funding for mesothelioma research.
• Mesothelioma sufferers and their families: Could indirectly benefit from improved treatments resulting from the research.
• Researchers: May have increased opportunities for funding.

Powered by nyModel